James Cooper
Overview
Explore the profile of James Cooper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
2799
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jain S, Maurer L, Cooper J, Correa D, Mccormick M, Devine K, et al.
Pediatr Blood Cancer
. 2025 Feb;
:e31589.
PMID: 39937535
Background: Management of neonatal portal vein thrombosis (PVT), a relatively common type of pediatric deep vein thrombosis, is not completely standardized. Questions remain about the benefit of anticoagulation (ATC) therapy...
2.
de Castro M, Jones S, de Las Heras J, Sanchez-Pintos P, Couce M, Colon C, et al.
Orphanet J Rare Dis
. 2024 Jun;
19(1):244.
PMID: 38918870
Background: Sebelipase alfa (Kanuma®) is approved for patients with Wolman disease (WD) at a dosage of 3-5 mg/kg once weekly. Survival rates in the second of two clinical trials was...
3.
Filingeri D, Mackey S, Soller H, Guarneri-Tragone A, Cooper J, Escobar O, et al.
Mol Genet Metab Rep
. 2024 Mar;
38:101058.
PMID: 38469098
Glycerol kinase deficiency (GKD) is a rare X-linked condition where glycerol cannot be phosphorylated to glycerol-3-phosphate, a key component of gluconeogenesis. Clinical presentation varies widely. We present a novel variant...
4.
Wu T, Brown H, Church H, Kershaw C, Hutton R, Egerton C, et al.
Mol Genet Metab
. 2024 Mar;
142(1):108349.
PMID: 38458124
Metachromatic leukodystrophy (MLD) is a devastating rare neurodegenerative disease. Typically, loss of motor and cognitive skills precedes early death. The disease is characterised by deficient lysosomal arylsulphatase A (ARSA) activity...
5.
Schold J, Conzen K, Cooper J, Arrigain S, Lopez R, Mohan S, et al.
J Am Soc Nephrol
. 2024 Feb;
35(5):630-641.
PMID: 38347668
No abstract available.
6.
Abrams C, Jaffray J, Stillings A, Branchford B, Young G, Goldenberg N, et al.
Res Pract Thromb Haemost
. 2023 Nov;
6(7):e12793.
PMID: 38024326
Background: A rise in hospital-acquired venous thromboembolism (HA-VTE) in children has led to increased awareness regarding VTE prophylaxis and risk assessment. Despite no consensus exists regarding these practices in pediatrics....
7.
Vieta E, Ghorpade S, Biswas A, Sarkar A, Phansalkar A, Cooper J
Eur Neuropsychopharmacol
. 2023 Sep;
78:81-92.
PMID: 37775363
This meta-analysis investigated the efficacy, safety, and tolerability of lamotrigine versus placebo in preventing relapse and recurrence of mood episodes in women of childbearing age with bipolar I disorder. Following...
8.
Banerjee P, Mehta A, Nirujogi R, Cooper J, James O, Nanda J, et al.
Sci Adv
. 2023 Apr;
9(16):eabq0651.
PMID: 37083530
Although microglial activation is widely found in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), the underlying mechanism(s) are poorly understood. Here, using human-induced pluripotent stem cell-derived microglia-like cells (hiPSC-MG)...
9.
Sik A, Kaveney-Gibb B, Cooper J, Pearson J, Larsen P, Rogan A
Emerg Med Australas
. 2022 Dec;
35(3):474-482.
PMID: 36529471
Objective: Concussion is a common ED complaint, but diagnosis is challenging as there are no validated objective measures. Use of concussion tools derived from sports medicine is common, but these...
10.
Zhang L, Zhang H, Lv L, Tan Q, Xu X, Hu J, et al.
Int J Bipolar Disord
. 2022 Jul;
10(1):20.
PMID: 35909213
Background: Lamotrigine is approved as a maintenance therapy for bipolar I disorder in many countries, including China in 2021. This study evaluated the efficacy and safety of lamotrigine in controlling...